Company
United StatesPublic company, NASDAQ: ATRAAtara Biotherapeutics, Inc. (NASDAQ: ATRA), Thousand Oaks, CA – FDA Inspections
Inspection records and compliance data for Atara Biotherapeutics, Inc. in Thousand Oaks, California. 1 FDA inspection on record, last inspected January 13, 2023. Publicly traded as NASDAQ: ATRA.
Company Profile
This profile covers Atara Biotherapeutics, Inc. based in Thousand Oaks, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected January 13, 2023.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 13, 2023 | NAI | Biologics · Bioresearch Monitoring | 1195416 |
FDA documents
Other FDA documents (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Atara Biotherapeutics, Inc.
Stock ticker
ATRA
Exchange
NASDAQ
Share price
$7.93
Market cap
$80.8M
Price as of
November 13, 2026
FEI Number
3021164562
Address
2380 Conejo Spectrum St Ste 200, Thousand Oaks, California 91320, United States
Country
United States
ID: 26473289-04b5-4e3e-805d-4e9b4cdd3c1c